Novel small-molecule inhibitors of SARS-CoV-2 main protease with nanomolar antiviral potency-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel small-molecule inhibitors of SARS-CoV-2 main protease with nanomolar antiviral potency

Published:2024-02 Issue:2 Volume:88 Page:211-214
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Zhang Haoran^ORCID,Zhou Kangping,Peng Fei^ORCID,Gao, Zhao,Song Guowei,Hu Bing,Chun Sophia,Xiao Junfeng,Qian Mengfei,Wu Jin,Pan Kai,Gao Fan,Guo Meng,Peng Cheng,Zou Gang,Wu Jim Zhen,Cai Kun^ORCID,Li Yan^ORCID

Publisher

Elsevier BV

Reference10 articles.

1. Targeting omicron and other reported SARS-CoV-2 lineages by potent inhibitors of main protease 3CL Mpro: Molecular simulation analysis;Saeed;J Infect,2022

2. Genetic and structural analyses reveal the low potential of the SARS-CoV-2 EG.5 variant;Scarpa;J Med Virol,2023

3. Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3;Zhang;Lancet Infect Dis,2023

4. The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells;Wenzel;Nat Neurosci,2021

5. Perspectives on SARS-CoV-2 main protease inhibitors;Gao;J Med Chem,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and biological evaluation of novel 3C-like protease inhibitors as lead compounds against SARS-CoV-2;Future Medicinal Chemistry;2024-04-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP